CLINICAL STUDIES
Early postoperative changes in regional systolic and diastolic left ventricular function after transmyocardial laser revascularization
A comparison of holmium:YAG and CO2 lasers
G. Chad Hughes, MDa,
Ashish S. Shah, MDa,
Bangliang Yin, MDa,
Ming Shu, PhDa,
Carolyn L. Donovan, MD, FACCa,
Donald D. Glower, MD, FACCa,
James E. Lowe, MD, FACCa and
Kevin P. Landolfo, MDa
a Duke University Medical Center, Durham, North Carolina, USA
Manuscript received March 25, 1999;
revised manuscript received October 15, 1999,
accepted November 22, 1999.
Reprint requests and correspondence: Dr. G. Chad Hughes, Box 3857, Duke University Medical Center, Durham, North Carolina 27710 chadh{at}acpub.duke.edu
OBJECTIVES
The purpose of this study was to determine the short-term effects of transmyocardial laser revascularization (TMR) on regional left ventricular systolic and diastolic function, myocardial blood flow (MBF) and myocardial water content (MWC).
BACKGROUND
Clinical studies of TMR have noted a significant incidence of cardiac complications in the early postoperative period. However, the early post-treatment effects of laser therapy on the myocardium and their potential contribution to postoperative cardiac morbidity are unknown.
METHODS
Swine underwent holmium:yttrium-aluminum-garnet (holmium:YAG) (n = 12) or carbon dioxide (CO2) (n = 12) laser TMR. Regional systolic function for the lased and nonlased regions was quantitated using preload recruitable work area (PRWA) and regional diastolic function with the ventricular stiffness constant alpha.
RESULTS
Preload recruitable work area was significantly decreased in the lased regions both 1 (59.8 ± 13.0% of baseline, p = 0.02) and 6 h (64.2 ± 9.4% of baseline, p = 0.02) after holmium:YAG TMR. This decreased PRWA was associated with a significant reduction in MBF to the lased regions (13.2% reduction at 1 h, p = 0.02; 18.4% decrease at 6 h post-TMR, p = 0.01). These changes were not seen after CO2 laser TMR. A significant increase in MWC (1.4 ± 0.3% increase with holmium:YAG, p = 0.004; 1 ± 0.2% increase with CO2, p = 0.002) and alpha (217.4 ± 44.2% of baseline 6 h post-holmium:YAG TMR, p = 0.05; 206 ± 36.7% of baseline 6 h post-CO2 TMR, p = 0.03) was seen after TMR with both lasers.
CONCLUSIONS
In the early postoperative setting, impaired regional systolic function in association with regional ischemia is seen after TMR with a holmium:YAG laser. Both holmium:YAG and CO2 lasers are associated with increased MWC and impaired diastolic relaxation in the lased regions. These changes may explain the significant incidence of early postoperative cardiac morbidity. The impact of these findings on anginal relief and long-term outcome are not known.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | CABG | = coronary artery bypass grafting | | CO2 | = carbon dioxide | | dP/dt | = first derivative of left ventricular transmural pressure | | EDL | = end diastolic segment length | | holmium:YAG | = holmium:yttrium-aluminum-garnet | | l | = regional segment length | | MBF | = myocardial blood flow | | MWC | = myocardial water content | | PRSW | = preload recruitable stroke work | | PRWA | = preload recruitable work area | | PTCA | = percutaneous transluminal coronary angioplasty | | SW | = stroke work | | TMR | = transmyocardial laser revascularization |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. Asai, S. Yamamoto, K. Ishino, T. Kohmoto, M. Kuriyama, G. Kato, Y. Oshima, N. Yamamoto, K. Notohara, S. Okada, et al.
Time-Dependent Regional Myocardial Denervation as a Nonspecific Response to Transmyocardial Laser Revascularization
Ann. Thorac. Surg.,
October 1, 2005;
80(4):
1362 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bridges, K. A. Horvath, W. C. Nugent, D. M. Shahian, C. K. Haan, R. J. Shemin, K. B. Allen, and F. H. Edwards
The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization
Ann. Thorac. Surg.,
April 1, 2004;
77(4):
1494 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol.,
January 15, 2003;
41(2):
173 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult,
January 1, 2003;
2(2003):
715 - 750.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. J. Laham, M. Simons, J. D. Pearlman, K. K. L. Ho, and D. S. Baim
Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization
J. Am. Coll. Cardiol.,
January 2, 2002;
39(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|